ENTASIS THERAPEUTICS HOLDINGS INC. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
ENTASIS THERAPEUTICS HOLDINGS INC. reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$1.24 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-04-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2022-04-27
- ENTASIS THERAPEUTICS HOLDINGS INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2022-03-31 was -$1.24M.
- ENTASIS THERAPEUTICS HOLDINGS INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2021-12-31 was $291.00K, a 82.86% decline year-over-year.
- ENTASIS THERAPEUTICS HOLDINGS INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2021-09-30 was -$1.26M, a 195.04% decline year-over-year.
- ENTASIS THERAPEUTICS HOLDINGS INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2021-06-30 was $1.30M.
- ENTASIS THERAPEUTICS HOLDINGS INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2021 was -$145.00K, a 114.00% decline from fiscal 2020.
- ENTASIS THERAPEUTICS HOLDINGS INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2020 was $1.04M, a 64.00% decline from fiscal 2019.
- ENTASIS THERAPEUTICS HOLDINGS INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2019 was $2.88M.
- ENTASIS THERAPEUTICS HOLDINGS INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2018 was -$2.28M, a 167.34% decline from fiscal 2017.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$1.24M 10-Q · filed 2022-04-27 | -$953.00K derived: sum of 2 quarters · filed 2022-04-27 | -$2.22M derived: sum of 3 quarters · filed 2022-04-27 | -$914.00K derived: sum of 4 quarters · filed 2022-04-27 |
| 2021-12-31 | $291.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | -$973.00K derived: sum of 2 quarters · filed 2022-03-03 | $330.00K derived: sum of 3 quarters · filed 2022-03-03 | -$145.00K 10-K · filed 2022-03-03 |
| 2021-09-30 | -$1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $39.00K derived: sum of 2 quarters · filed 2021-11-04 | -$436.00K 10-Q · filed 2021-11-04 | $1.26M derived: sum of 4 quarters · filed 2022-04-27 |
| 2021-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $828.00K 10-Q · filed 2021-08-12 | $2.53M derived: sum of 3 quarters · filed 2022-04-27 | $3.86M derived: sum of 4 quarters · filed 2022-04-27 |
| 2021-03-31 | -$475.00K 10-Q · filed 2022-04-27 | $1.22M derived: sum of 2 quarters · filed 2022-04-27 | $2.55M derived: sum of 3 quarters · filed 2022-04-27 | $2.50M derived: sum of 4 quarters · filed 2022-04-27 |
| 2020-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $3.03M derived: sum of 2 quarters · filed 2022-03-03 | $2.97M derived: sum of 3 quarters · filed 2022-03-03 | $1.04M 10-K · filed 2022-03-03 |
| 2020-09-30 | $1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.27M derived: sum of 2 quarters · filed 2021-11-04 | -$662.00K 10-Q · filed 2021-11-04 | -$534.00K derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -$58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$1.99M 10-Q · filed 2021-08-12 | -$1.86M derived: sum of 3 quarters · filed 2021-08-12 | -$2.37M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$1.93M 10-Q · filed 2021-05-05 | -$1.81M derived: sum of 2 quarters · filed 2021-05-05 | -$2.31M derived: sum of 3 quarters · filed 2021-05-05 | -$973.00K derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $128.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-30 | -$374.00K derived: sum of 2 quarters · filed 2021-04-30 | $961.00K derived: sum of 3 quarters · filed 2021-04-30 | $2.88M 10-K/A · filed 2021-04-30 |
| 2019-09-30 | -$502.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $833.00K derived: sum of 2 quarters · filed 2020-11-05 | $2.75M 10-Q · filed 2020-11-05 | $856.00K derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $3.25M 10-Q · filed 2020-08-06 | $1.36M derived: sum of 3 quarters · filed 2020-08-06 | $1.82M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $1.92M 10-Q · filed 2020-05-07 | $23.00K derived: sum of 2 quarters · filed 2020-05-07 | $482.00K derived: sum of 3 quarters · filed 2020-05-07 | $1.92M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | -$1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | -$1.44M derived: sum of 2 quarters · filed 2020-03-11 | -$2.00K derived: sum of 3 quarters · filed 2020-03-11 | -$2.28M 10-K · filed 2020-03-11 |
| 2018-09-30 | $459.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $1.89M derived: sum of 2 quarters · filed 2019-11-14 | -$386.00K 10-Q · filed 2019-11-14 | $2.76M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$845.00K 10-Q · filed 2019-08-12 | $2.30M derived: sum of 3 quarters · filed 2019-08-12 | |
| 2018-03-31 | -$2.28M 10-Q · filed 2019-05-14 | $867.00K derived: sum of 2 quarters · filed 2019-05-14 | ||
| 2017-12-31 | $3.15M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $3.39M 10-K · filed 2019-03-29 | ||
| 2017-09-30 | $241.00K 10-Q · filed 2018-11-14 |